| Family |
Plantaginaceae |
| Tribe |
Plantagineae |
| Scientific name |
Plantago asiatica L. |
| Synonyms |
Plantago asiatica L. forma ochranthera Mizushima; Plantago asiatica L.
var. densiuscula Pilger; Plantago asiatica L. var. lobulata Pilger; Plantago
asiatica L. var. sphaerocarpa Kitagawa; Plantago asiatica L. var. yezoensis
(Pilger) H. Hara; Plantago coreana H. Léveillé; Plantago formosana Tateishi
& Masamune; Plantago major L. var. asiatica (L.) Decaisne; Plantago
yezoensis Pilger |
| Common name |
(Japanese common name) ohbako (オオバコ, 大葉子 [meaning: large leaves]) |
| (English common name) none |
| Distribution |
(Japan) Hokkaido, Honshu, Shikoku, Kyushu, Okinawa |
| (Other nations) Korea, China, Taiwan, Malaysia, Indonesia, India |
| Habitat |
Roadside |
| Chromosomal number |
2n=12 (2x), 24 (4x), 36 (6x) |
| Description |
Scapes 10-20cm tall. Leaves 4-5cm long, 3-8cm wide. Flowers calyxs ca.
2mm long, bracts shorter than calyxs, flowering in June to September. Perennial
plants. |
| Reference |
Plantago asiatica L. |
| Plantago asiatica L. f. ochranthera Mizushima |
| Plantago asiatica L. var. sphaerocarpa Kitagawa |
| DNA Authentication of Plantago Herb Based on Nucleotide Sequences of 18S-28S
rRNA Internal Transcribed Spacer Region(Pharmacognosy) |
| Ecotypic differentiation of Plantago asiatica L. in Hapan Islands |
| Chemotaxonomy and evolution of Plantago L. |
| Combinations of diterpene triepoxide lactones and ditepene lactones or
triterpenes for synergistic inhibition of cyclooxygenase-2 (US Patent 6629835/2003) |
| Preventive or therapeutic agent for pollen allergy, allergic rhinitis,
atopic dermatitis, asthma or urticaria, or health food for prevention or
improvement or reduction of symptoms thereof (US Patent 6811796/2004) |
| Herbal compositions for prostate conditions (US Patent 6790464/2004) |
| Curcuminoid compositions exhibiting synergistic inhibition of the expression
and/or activity of cyclooxygenase-2 (US Patent 6979470/2005) |
| Compositions that treat or inhibit pathological conditions associated with
inflammatory response (US Patent 7270835/2007) |
| Reduction inhibitory agent for active-oxygen eliminating activity (US Patent
7186824/2007) |
| Lipolysis stimulator (US Patent 7300675/2007) |
| Composition for treating hepatitis C (US Patent 7381435/2008) |
